| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A prospective multicentre trial on survival after Microwave Ablation VErsus Resection for Resectable Colorectal liver metastases (MAVERRIC)
|
Tinguely, Pascale
|
|
|
187 |
C |
p. 65-76
|
artikel
|
| 2 |
Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective Analysis
|
Hench, Juergen
|
|
|
187 |
C |
p. 7-14
|
artikel
|
| 3 |
Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study
|
Normanno, Nicola
|
|
|
187 |
C |
p. 174-184
|
artikel
|
| 4 |
Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era—Is it time for a new paradigm shift? A systematic review and meta-analysis
|
Peters, Inge T.A.
|
|
|
187 |
C |
p. 77-86
|
artikel
|
| 5 |
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup
|
Rubatto, Marco
|
|
|
187 |
C |
p. 25-35
|
artikel
|
| 6 |
Do more targets allow more cancer treatments, or not?
|
Marchetti, Paolo
|
|
|
187 |
C |
p. 99-104
|
artikel
|
| 7 |
European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care
|
Cardoso, Fatima
|
|
|
187 |
C |
p. 105-113
|
artikel
|
| 8 |
Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma: RELATIVITY-047 trial
|
Schadendorf, Dirk
|
|
|
187 |
C |
p. 164-173
|
artikel
|
| 9 |
Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design
|
van Hulst, Annelienke M.
|
|
|
187 |
C |
p. 124-133
|
artikel
|
| 10 |
Intracranial response of brain metastases in patients with HER2-amplified breast cancer treated with trastuzumab-deruxtecan after failure of tucatinib-based therapy
|
Desmoulins, Isabelle
|
|
|
187 |
C |
p. 161-163
|
artikel
|
| 11 |
Letter re: SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis
|
Baba, Atsunori
|
|
|
187 |
C |
p. 96-98
|
artikel
|
| 12 |
Mental health outcomes in older breast cancer survivors: Five-year follow-up from the CLIMB study
|
Lemij, Annelieke A.
|
|
|
187 |
C |
p. 87-95
|
artikel
|
| 13 |
Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunity
|
Chung, Rainjade
|
|
|
187 |
C |
p. 58-64
|
artikel
|
| 14 |
Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus
|
Desmedt, Valérie
|
|
|
187 |
C |
p. 36-57
|
artikel
|
| 15 |
Re: A low prostate-specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer
|
Ning, Hao
|
|
|
187 |
C |
p. 144-146
|
artikel
|
| 16 |
Sex differences in treatment allocation and survival of potentially curable gastroesophageal cancer: A population-based study
|
Kalff, Marianne C.
|
|
|
187 |
C |
p. 114-123
|
artikel
|
| 17 |
Shining a LIGHT on myeloid cell targeted immunotherapy
|
Shuptrine, Casey W.
|
|
|
187 |
C |
p. 147-160
|
artikel
|
| 18 |
The ethics of risk-stratified cancer screening
|
Dennison, Rebecca A.
|
|
|
187 |
C |
p. 1-6
|
artikel
|
| 19 |
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours
|
Bossi, Paolo
|
|
|
187 |
C |
p. 134-143
|
artikel
|
| 20 |
The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours
|
Resteghini, Carlo
|
|
|
187 |
C |
p. 185-194
|
artikel
|
| 21 |
Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors
|
Manca, Paolo
|
|
|
187 |
C |
p. 15-24
|
artikel
|
Tijdschrift beschrijving